Crispact® Capsules

Crispact® Capsules (Finalist for the Vitafoods Europe Innovation Award 2025 as most innovative ready-to-use product) is the new format of Crispact®, offering the same clinically validated potential for vaginal health support. It harnesses the power of Lactobacillus crispatus M247, an exclusive and patented probiotic strain, to help maintain and restore a healthy vaginal microbiota, prevent infections, and promote overall vaginal well-being. Crispact® has been clinically studied in HPV-infected women, demonstrating its ability to promote viral clearance and regression of cervical lesions. Additionally, it has been shown to support women undergoing assisted reproductive technology (ART) procedures by promoting conception and increasing live birth rates. Now available in a convenient capsule format, Crispact® Capsules deliver the same high efficacy and innovation that have made the original product a breakthrough in women's health.